Literature DB >> 21087605

Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells.

Tzu-Yen Fu1, Chia-Che Chang, Chun-Ting Lin, Cong-Hao Lai, Shao-Yu Peng, Yi-Ju Ko, Pin-Chi Tang.   

Abstract

Basigin (Bsg), also called extracellular matrix metalloproteinase inducer (EMMPRIN), is highly expressed on the surface of tumor cells and stimulates adjacent fibroblasts or tumor cells to produce matrix metalloproteinases (mmps). It has been shown that Bsg plays an important role in growth, development, cell differentiation, and tumor progression. MicroRNAs (miRNAs) are a class of short endogenous non-protein coding RNAs of 20-25 nucleotides (nt) that function as post-transcriptional regulators of gene expression by base-pairing to their target mRNAs and thereby mediate cleavage of target mRNAs or translational repression. In this study, let-7b, one of the let-7 family members, was investigated for its effect on the growth and invasiveness of the mouse melanoma cell line B16-F10. We have shown that let-7b can suppress the expression of Bsg in B16-F10 cells and also provided evidence that this suppression could result in the indirect suppression of mmp-9. The ability of B16-F10 cells transfected with let-7b to invade or migrate was significantly reduced. In addition, let-7b transfected B16-F10 cells displayed an inhibition of both cellular proliferation and colony formation. Furthermore, it was shown that the overexpression of let-7b in B16-F10 cells could reduce lung metastasis. Taken together, the present study identifies let-7b as a tumor suppressor that represses cancer cell proliferation and migration as well as tumor metastasis in mouse melanoma cells. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087605     DOI: 10.1016/j.yexcr.2010.11.004

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  29 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

Review 2.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

Review 3.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

4.  Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA.

Authors:  Andrea Marranci; Romina D'Aurizio; Sebastian Vencken; Serena Mero; Elena Guzzolino; Milena Rizzo; Letizia Pitto; Marco Pellegrini; Giovanna Chiorino; Catherine M Greene; Laura Poliseno
Journal:  RNA Biol       Date:  2019-04-19       Impact factor: 4.652

Review 5.  Regulation of microRNAs in cancer metastasis.

Authors:  Juliette M C Bouyssou; Salomon Manier; Daisy Huynh; Samar Issa; Aldo M Roccaro; Irene M Ghobrial
Journal:  Biochim Biophys Acta       Date:  2014-02-22

6.  Let-7b and microRNA-199a inhibit the proliferation of B16F10 melanoma cells.

Authors:  Dan Xu; Jianxiang Tan; Ming Zhou; Bimei Jiang; Huiqing Xie; Xinmin Nie; Kun Xia; Jianda Zhou
Journal:  Oncol Lett       Date:  2012-08-23       Impact factor: 2.967

Review 7.  Mutual regulation of microRNAs and DNA methylation in human cancers.

Authors:  Sumei Wang; Wanyin Wu; Francois X Claret
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

8.  The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.

Authors:  Xiaowen Hu; Jinyi Guo; Lan Zheng; Chunsheng Li; Tim M Zheng; Janos L Tanyi; Shun Liang; Chiara Benedetto; Marco Mitidieri; Dionyssios Katsaros; Xia Zhao; Youcheng Zhang; Qihong Huang; Lin Zhang
Journal:  Mol Cancer Res       Date:  2013-01-21       Impact factor: 5.852

9.  Prognostic significance of let-7b expression in breast cancer and correlation to its target gene of BSG expression.

Authors:  Lin Ma; Gui-Zhu Li; Zheng-Sheng Wu; Gang Meng
Journal:  Med Oncol       Date:  2013-11-22       Impact factor: 3.064

Review 10.  MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.

Authors:  Anita Thyagarajan; Ahmed Shaban; Ravi Prakash Sahu
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.